Prostap SR DCS 3.75mg pdr and solvent for prolonged-rel inj
0803042N0BBACAC · Malignant Disease and Immunosuppression
4,264items
Dispensed in April 2026
NHSBSA Prescription Cost Analysis
£329,025
Net ingredient cost · April 2026
NHSBSA PCA
52,131items
Dispensed in the last 12 months
NHSBSA PCA
Figure 1. Prostap SR DCS 3.75mg pdr and solvent for prolonged-rel inj: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to April 2026
One presentation of Leuprorelin acetate. See the chemical for the full national picture and related presentations.
Top dispensing practices
Dispensing GP practices supplying this presentation, by items (a subset of national dispensing).
| Practice | Items |
|---|---|
| Holderness Health | 189 |
| The Ridings Medical Group | 176 |
| Dinnington Group Practice | 169 |
| Modality Partnership (awc) | 163 |
| Morthen Road Surgery | 155 |
| Westrop Medical Practice | 145 |
| Lancaster Medical Practice | 143 |
| Lakeside Healthcare Stamford | 126 |
| Winterton Medical Practice | 121 |
| South Axholme Practice | 105 |